Back to top
more

Veeva Systems (VEEV)

(Real Time Quote from BATS)

$281.02 USD

281.02
350,944

-0.44 (-0.16%)

Updated Aug 6, 2025 02:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 246)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

Here's Why Veeva Systems (VEEV) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Reasons to Retain Veeva Systems (VEEV) in Your Portfolio Now

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock. However, data security threats and escalating costs are a concern.

Zacks Equity Research

Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Veeva Systems (VEEV) closed at $187.92, marking a +1.04% move from the previous day.

Zacks Equity Research

Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Veeva's (VEEV) Vault EDC to Boost Vita Global's Data Management

Veeva's (VEEV) Vault EDC is likely to improve Vita Global's clinical data management processes.

Zacks Equity Research

Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

3 Reasons to Hold Veeva Systems (VEEV) Stock in Your Portfolio

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.

Zacks Equity Research

Veeva Systems' (VEEV) Vault EDC to Boost Tigermed's Workflow

Veeva Systems' (VEEV) Vault EDC is likely to streamline key processes to accelerate study builds and make mid-study amendments with no downtime.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Don't Overlook Veeva (VEEV) International Revenue Trends While Assessing the Stock

Review Veeva's (VEEV) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks Equity Research

Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.

Zacks Equity Research

Veeva Systems (VEEV) Q1 Earnings Beat Estimates, Margins Up

Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performance by both segments.

Zacks Equity Research

Veeva (VEEV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Veeva (VEEV) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Veeva Systems (VEEV) Q1 Earnings and Revenues Top Estimates

Veeva (VEEV) delivered earnings and revenue surprises of 4.90% and 1.34%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Pure Storage (PSTG) Surpasses Q1 Earnings and Revenue Estimates

Pure Storage (PSTG) delivered earnings and revenue surprises of 45.45% and 1.78%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Box (BOX) Q1 Earnings and Revenues Beat Estimates

Box (BOX) delivered earnings and revenue surprises of 8.33% and 1.15%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Veeva Systems (VEEV) Stock Dips While Market Gains: Key Facts

Veeva Systems (VEEV) concluded the recent trading session at $203.89, signifying a -0.34% move from its prior day's close.

Zacks Equity Research

Veeva (VEEV) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Get a deeper insight into the potential performance of Veeva (VEEV) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Equity Research

Workday (WDAY) Q1 Earnings and Revenues Surpass Estimates

Workday (WDAY) delivered earnings and revenue surprises of 10.83% and 0.84%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Veeva Systems (VEEV) Stock Drops Despite Market Gains: Important Facts to Note

Veeva Systems (VEEV) closed the most recent trading day at $209.24, moving -0.34% from the previous trading session.

Zacks Equity Research

Palo Alto Networks (PANW) Tops Q3 Earnings and Revenue Estimates

Palo Alto (PANW) delivered earnings and revenue surprises of 5.60% and 0.91%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Masimo's (MASI) New Offering to Serve Personalized Audio Market

Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.

Zacks Equity Research

Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?

Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.

Zacks Equity Research

Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know

Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.